Skip to main content
Premium Trial:

Request an Annual Quote

Protagen Completes $5.3M Funding Round

NEW YORK (GenomeWeb News) – Protagen has received €3.7 million ($5.3 million) in funding from existing institutional European investors, the company said today.

The company plans to use the funding to expand its UNIarray technology and patent position and to clinically validate proprietary diagnostic marker proteins. These efforts will focus on developing serum-based molecular diagnostic tests for early detection of multiple sclerosis and for differential diagnosis of prostate cancer.

The investors involved in this funding round include MIG AG, S-Capital Dortmund, and Kreditanstalt für Wiederaufbau.

The company has protein research operations in Dortmund, Germany, and in Chester, NJ.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.